Better protection for human subjects is outcome of very early clinical trials.
Maloney
Dennis M
DM
The Deem Corporation, P.O. Box 44069, Omaha, NE 68144, USA.
D017321:Clinical Trials, Phase I as Topic / Q000331:legislation & jurisprudence* / Q000379:methods* / Q000592:standards; D004353:Drug Evaluation, Preclinical; D006805:Human Experimentation / Q000331:legislation & jurisprudence; D006801:Humans; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration